Inhibition of activated factor viii by sulfhydryl modification reagents
Orthner, C.L.; Migliorini, M.M.
Federation Proceedings 46(6): 2243
1987
ISSN/ISBN: 0014-9446 Accession: 028539272
PDF emailed within 1 workday: $29.90
Related References
Feng, Y.; Forgac, M. 1992: Cysteine 254 of the 73-kDa a subunit is responsible for inhibition of the coated vesicle (H+)-ATPase upon modification by sulfhydryl reagents Journal of Biological Chemistry 267(9): 5817-5822Woltjer, R.L.; Staros, J.V. 1997: Effects of sulfhydryl modification reagents on the kinase activity of the epidermal growth factor receptor Biochemistry 36(32): 9911-9916
Smith, C.; Triplett, D.A. 1981: Sensitivity of commercial activated partial thromboplastin times reagents to mild factor viii and factor ix deficiencies American Journal of Clinical Pathology 75(6): 867
Mischke, R. 2000: Influence of factor VIII:C and factor IX activity in plasmas of haemophilic dogs on the activated partial thromboplastin time measured with two commercial reagents Haemophilia: the Official Journal of the World Federation of Hemophilia 6(3): 135-139
Waldron, G.J.; Murrell Lagnado, R.D. 2000: Inhibition of G-protein activated, inwardly rectifying potassium channels by sulfhydryl modification Biophysical Journal 78(1 Part 2): 346A
Kraker, A.J.; Wemple, M.J.; Moore, C.W. 1992: Effect of sulfhydryl reagents on the inhibition of epidermal growth factor egf receptor tyrosine kinase by erbstatin Proceedings of the American Association for Cancer Research Annual Meeting 33: 85
Bloom, A.L. 1981: Inhibition of activated protein c in combined factor v factor viii deficiency Thrombosis and Haemostasis: 61
King, M.M. 1985: Modification of calcineurin by sulfhydryl reagents Federation Proceedings 44(3): 707
Arai, M.; Scandella, D.; Hoyer, L.W. 1989: Molecular basis of factor VIII inhibition by human antibodies. Antibodies that bind to the factor VIII light chain prevent the interaction of factor VIII with phospholipid Journal of Clinical Investigation 83(6): 1978-1984
Fay, P.J.; Walker, F.J. 1989: Inactivation of human factor VIIi by activated protein C: evidence that the factor VIIi light chain contains the activated protein C binding site Biochimica et Biophysica Acta 994(2): 142-148
Eaton, D.; Rodriguez, H.; Vehar, G.A. 1986: Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIIi coagulant activity Biochemistry 25(2): 505-512
Godin, D.V.; Schrier, S.L. 1972: Modification of the erythrocyte membrane by sulfhydryl group reagents Journal of Membrane Biology 7(1): 285-312
Sultan, Y.; Loyer, F. 1993: In vitro evaluation of factor VIII--bypassing activity of activated prothrombin complex concentrate, prothrombin complex concentrate, and factor VIIa in the plasma of patients with factor VIIi inhibitors: thrombin generation test in the presence of collagen-activated platelets Journal of Laboratory and Clinical Medicine 121(3): 444-452
Hultin, M.B.; Nemerson, Y. 1978: Activation of factor X by factors IXa and VIII; a specific assay for factor IXa in the presence of thrombin-activated factor VIIi Blood 52(5): 928-940
King, M.M. 1986: Modification of the calmodulin-stimulated phosphatase, calcineurin, by sulfhydryl reagents Journal of Biological Chemistry 261(9): 4081-4084